Mr. Ullem serves as the Corporate Vice President and Chief Financial Officer at Edwards Lifesciences Corp, a global leader in patient-focused medical innovations for structural heart disease and critical care monitoring. In his role, Mr. Ullem is responsible for overseeing the company's financial operations, including financial planning and analysis, accounting, tax, treasury, and investor relations. His strategic financial leadership has been instrumental in driving Edwards Lifesciences' growth and success in the competitive medical technology industry. Prior to joining Edwards Lifesciences, Mr. Ullem held various senior financial positions at Allergan, a pharmaceutical company, where he honed his skills in financial management and corporate strategy. His extensive experience in the healthcare sector, combined with his strong financial acumen, has enabled him to make significant contributions to Edwards Lifesciences' financial performance and long-term sustainability. Under his leadership, the company has consistently delivered strong financial results and maintained a solid balance sheet, positioning it well for future growth and innovation. Mr. Ullem's achievements at Edwards Lifesciences include successfully navigating the company through complex financial challenges, such as the global economic downturn and the impact of the COVID-19 pandemic on the healthcare industry. His ability to adapt to changing market conditions and implement effective financial strategies has been crucial in maintaining the company's financial stability and supporting its mission to improve patient outcomes. As a key member of the executive team, Mr. Ullem continues to play a vital role in shaping Edwards Lifesciences' financial strategy and driving the company's long-term success.